{
  "id": 18734713,
  "title": "Decoding Healthcare ETFs: Different Sectors, Different Strategies",
  "url": "https://urgent.news/2026/11/07/decoding-healthcare-etfs-different-sectors-different-strategies",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-07T15:15:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/11/07/decoding-healthcare-etfs-different-sectors-different-strategies/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "The Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and the State Street SPDR S&P Biotech ETF (XBI) are two distinct healthcare ETFs with varying strategies and risk-reward profiles. RSPH offers balanced exposure to the healthcare sector, tracking an equal-weighted index with 98% of its assets in healthcare and small exposures to technology. It has a higher dividend yield of 0.6% and a stronger 5-year CAGR of 6.6%, making it an appealing option for investors seeking long-term, stable growth. On the other hand, XBI is more focused and volatile, targeting the biotechnology sector with 99% of its portfolio dedicated to healthcare and biotech stocks. While it has a lower dividend yield of 0.4%, its 5-year CAGR of 2.6% may still appeal to investors seeking higher growth potential. Ultimately, the choice between these two ETFs will depend on an investor's risk tolerance, investment horizon, and specific goals.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}